Submissions

Online Submissions

Already have a Username/Password for Jurnal Kedokteran dan Kesehatan Indonesia?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

Author Guideline

Jurnal Kedokteran dan Kesehatan Indonesia accepts manuscripts written in Indonesian or English that should not have been published previously and must not be under simultaneous consideration by any other journal. Jurnal Kedokteran dan Kesehatan Indonesia accept an original article, case report and also a review article.

Article types

A. Original/Research Article

Original contributions are manuscripts containing substantial novel research. These articles can include randomised controlled trials, observational (cohort, case-control or cross-sectional) studies, diagnostic accuracy studies, systematic reviews and meta-analyses, nonrandomized behavioural and public health intervention trials, experimental animal trials, or any other clinical or experimental studies.

Manuscript Preparation

The manuscript should be formatted as follows: paper size A4, use double-spacing in a Times new roman font, 12-point and limited to approximately 16 pages in length including references, tables and figures. Number pages consecutively in the bottom centre of each page, beginning with the title page. Each manuscript component should begin on a new page in the following sequence:

  1. Title Page
    • The title page should contain the title, name of an author, name of the Department or Agency, Author’s full name and address for correspondence (electronic, non-electronic, telephone number).
    • The title should informative, written in uppercase / capital, bold with font Times New Roman size 14, single-spaced and located in the middle (center). Long title should be divided into subheadings.
    • Name of the author should be written in Times New Roman size 10, located in the middle, under the title, without an academic degree and starting from the first author followed by the second author, third and so on. Name of each author should in capitalised for each word. The abbreviation should be written as a superscript to all the author. Authors should avoid the use of non-standard abbreviations.
  2. Abstract
    • A structured abstract that contains no more than 250 words typed in single-space and written in font Times New Roman size 11. The abstract should consist of background, objective, methods, results, conclusions. Below the abstract, provide a list of 3–10 keywords. Abstract should be written in two languages, Indonesian and English. Use straight letter for the abstract in Bahasa Indonesia and Italics for abstract in English (should also include a title in English). The content of each section should be presented in the ‘Justify’ paragraph with no ‘First line indent’.
  3. Introduction
    • This section should be written without subtitle, contain background information such as prior work and the objective of the study. Describe the rationale of the study (need and significance). Summarise the previous relevant research and explains the author’s finding (pro and kontra results). Describe the novelty of the study and the objective of the study.
  4. Research Methodology
    • Should be described in detail, including research design, Study subjects, population, sample size determination, data sources, data collection techniques/instruments, intervention, measurements, laboratory analysis, statistical analysis, ethical clearance as well as research place and period.
    • Units of Measurement. Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or litre) or their decimal multiples. Temperatures should be in degrees Celsius. Blood pressures should be in millimetres of mercury unless other units are specifically required by the journal.
    • Statistical Methods. In manuscripts that report on randomised clinical trials, authors may provide a flow diagram in CONSORT format and all of the information required by the CONSORT checklist. The CONSORT statement, checklist, and flow diagram are available on the Consort website. For tables comparing treatment groups in a randomized trial (usually the first table in the trial report), significant differences between or among groups (i.e. p<0.005) should be identified. In general, p values should be reported to three decimal places (i.e. p<0.001).
    • Ethics. Authors are required to describe in their manuscripts ethical approval from an appropriate committee and how consent was obtained from participants when research involves human participants and animals. For articles concerning experimental research on humans, a statement should be included that shows informed consent of subjects was obtained following a detailed explanation of the procedures that they may undergo. 
  5. Result
    • This section may be divided by subheadings. It should provide a concise and precise description of the experimental results and their interpretation. Tables or figures should be numbered in the text sequentially, written in single-space, font Times New Roman size 11. The title should be precise and clear, located above the table. The title of pictures should be short and clear, located below the image. Both titles should be placed align left and suitable for the image and also a table.
    • The maximum number of tables or pictures are six (6) in one (1) manuscript. Do not use internal horizontal or vertical lines. Give each column a short or abbreviated heading. Authors should place the explanatory matter in footnotes, not in the heading. Figures should be either professionally drawn and photographed, or submitted as photographic quality digital prints. For x-ray films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, send sharp, glossy, black-and-white or colour photographic prints. Tables and tables consecutively in the order of their first citation in the text and supply a brief title for each. If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher except for documents in the public domain.
  6. Discussion
    • Summarise the major findings. Compare your results with previous work. Discuss the scientific of your findings. Limitations of the study. Clinical implication of the study. Future directions.
  7. Conclusion
    • Consist of Conclusion and also suggestion. Conclusion should be the answer of research problem, unequivocal statement. Suggestion should be logical and appropriate.
  8. Conflict of Interest
    • Authors should made a conflict of interests disclosure statement or a declaration that they do not have any conflicts of interest. Authors should disclose at the time of revision any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial.
  9. Acknowledgements
    • Anyone (individual/company/institution) who has substantially contributed to the study for important intellectual content must be acknowledged. Acknowledge only persons who have made substantive contributions to the study.
  10. References
    • It is the authors’ responsibility to check all references very carefully for accuracy and completeness. References must be one-spaced, in size 11 and numbered consecutively as they are cited. References should be in Vancouver style (superscripted Arabic numerals). References first cited in a table or figure should be numbered so they will be in sequence with the references cited in the text at the point where the table or figure is first mentioned.  The minimal number of references should be 15 and 85% of them should be recent (published during the last 10 years). Authors is recommended to use reference management software Mendeley®. Examples of correct references are given at the end of these instructions.

B. Case Report
Case report usually describes one to three patients or a single family. Case report containing a substantial novel finding should be unique, representing a diagnostic or therapeutic challenge and having a learning point for the readers. The title page: The words “case report” or “case study” should appear in the title along with the phenomenon of greatest interest (e.g., symptom, diagnosis, test, intervention).

  • Abstract: An unstructured abstract should be performed for a case report. An abstract should consist Introduction (What does this case add), case presentation (The main symptoms of the patient, the main clinical findings, the main diagnoses and interventions. and the main outcomes), and conclusion (What were the main “take-away” lessons from this case). The abstract should be limited to a maximum of 250 words. A case report is limited to 2000 words. To find and download the Microsoft Word template. Download the template.
  • The text of a case report should be made a brief but complete (adopted from CARE guidelines):
      • Introduction: should contain definition and background of the problem, or experience of other people's writing briefly about the same issues and the interests of the case, a reason for reporting.
      • Case description: Describe the relevant patient information, physical examination findings, diagnostic methods, therapeutic intervention, follow-up and outcomes.
        • Patient information: consist of demographic information (eg, age, gender, ethnicity, occupation), main symptoms of the patient (his or her chief complaints), medical, family, and psychosocial history—including diet, lifestyle, and genetic information whenever possible, and details about relevant comorbidities including past interventions and their outcomes.
        • Diagnostic methods: include laboratory testing, imaging, questionnaires, diagnostic challenges (e.g., financial, language/cultural), diagnostic reasoning including other diagnoses considered and prognostic characteristics (e.g., staging) where applicable.
        • Follow-up and outcomes: Summarize the clinical course of all follow-up visits including Clinician and patient-assessed outcomes, Important follow-up test results (positive or negative), intervention adherence and tolerability (and how this was assessed), and adverse and unanticipated events.
      • Discussion: The strengths and limitations of the management of the case, The relevant medical literature, the rationale for conclusions (including assessments of cause and effect, and the main “take-away” lessons of this case report. Review of Literature should be appropriate and closely related to the case. Rooted in the study of literature is made, then made a summary as a basis for discussion.
      • Conclusion, references and other provisions of writing are similar to those of the original article.

C. Review Article
The manuscript should contain a comprehensive analysis of a specific topic and limited to 5000 words. An unstructured abstract should be performed for this manuscript. The manuscript should  describe the problem and contain enough resource material for related research. The discussion should be appropriate with the issues discussed in the literature review, mixed with opinions and arguments, which are relevant to the problems. The conclusion should be according to the summary and discussion.

Examples of correct forms of references
Journal Article with Individual Author
Winarno ANS. Kerley a line in an 18-year-old female with acute pulmonary edema and chronic kidney disease stage V. Jurnal Kedokteran dan Kesehatan Indonesia. 2017;8(1):38–44.
Journal Article with Organizational Author
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679–86.
Journal Article from Internet
Goodyear-Smith FA, Arroll B. Contraception before and after termination of pregnancy: can we do it better? [Internet]. Vol. 116, The New Zealand medical journal. 2003. p. U683. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14657966
Book named by Editor as Author
Lewis G. Why Mothers Die. Report on confidential enquiries into maternal deaths in the United Kingdom, 2000-2002. Lewis G, editor. London: RCOG Press; 2004.
Books Written by Individuals
Lock S. Death in Childbirth: An International Study of Maternal Care and Maternal Mortality 1800-1950. London: Oxford University Press; 1992. 338–339. p.
Books Written by Organization
Council of Europe. Recent Demographic Developments in Europe 2004. Strasbourg, France: Council of Europe Publishing; 2005.
Article from Buletin
Ali MM, Cleland J, Shah IH. Condom use within marriage: A neglected HIV intervention. Bulletin of the World Health Organization. 2004;180–6.
Paper Presented at the Scientific Meeting / Conference
Desrini S, Ghiffary HM. Comparison of antibacterial activity of Talok (Muntingia calabura L) leaves ethanolic and n-hexane extracts on Propionibacterium acnes. In: AIP Conference Proceedings. 2018.
Chapter in Book
Singh S, Henshaw SK, Berensten K. Abortion: a worldwide overview. In: Basu AM, editor. The Sociocultural and Political Aspects of Abortion: Global Perspectives. Westport: Praeger Publishers; 2003. p. 15–47.
Data from Internet
U.S. Bureau of the Census. International Data Base [Internet]. China; 2007 [cited 2009 Aug 12]. Available from: http://www.census.gov/ipc/www/idb/country/chportal.html
Dissertation / Thesis
Kinyanda E. Deliberate self-harm in urban Uganda?: a case-control study. Norwegian University of Science and Technology; 2006.
Paper in Newspaper
Banzai VK, Beto JA. Treatment of Lupus Nephritis. The Jakarta Post. 1989 Dec 8;A5 (col 3).
Dictionary / Ensiklopedia
Saunders E. Dorland’s Illustrated Medical Dictionary. In: 27th ed. 2012. p. 632–1940.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. Cover letter.
    It includes the following information:
    • Title of the submitted manuscript
    • List of all authors’ names and affiliations
    • A short statement of the precise problem or objective addressed in the paper
    • List of other journal or conference papers (if any) submitted or published by you or any co-author that have a significant overlap with the contribution submitted here accompanied by a brief explanation of the nature of this overlap pointing out clearly which novel ideas submitted here have not been discussed in these prior publications
    • The names and emails of three experts (someone who has published several high-quality papers in the last five years and as an expert one of  areas and fields that you listed above)  covering these areas and fields
  2. Statement of originality which stated that the submitted manuscript is free from plagiarism
  3. Letter of approval from the local Committee of Ethical Research
  4. Declaration of interest. All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Authors must supply ICMJE conflicts of interest statement form. Authors can download the COI form on this website.
 

Copyright Notice

Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:

  1. Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
  2. Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.